BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Description

The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.

Conditions

Bone Marrow Transplant Complications, Hematologic Malignancy

Talk to us

Study Overview

On this page

Study Details

Study overview

The goal of this study is to evaluate whether a psychological intervention (BMT-CARE) is effective at improving the quality of life in caregivers and patients treated with hematopoietic cell transplant compared to usual care, and to identify critical facilitators and barriers for BMT-CARE implementation and adoption.

Multimodal Psychosocial Intervention for Caregivers of Patients Undergoing Hematopoietic Stem Cell Transplantation

BMT-CARE: Psychosocial Intervention for Transplant Caregivers

Condition
Bone Marrow Transplant Complications
Intervention / Treatment

-

Contacts and Locations

Birmingham

University of Alabama at Brimingham, Birmingham, Alabama, United States, 35294

Tampa

Moffitt Cancer Center, Tampa, Florida, United States, 33612

Boston

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States, 02114

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult caregivers (≥18 years) who is a relative or friend whom the patient identified as living with them or having in-person contact with them at least twice a week.
  • * Caregiver of a patient receiving allogeneic or autologous HCT for the treatment of cancer.
  • * Ability to read and respond to survey questions in English, Spanish or with minimal assistance from an interpreter.
  • * Caregivers of patients undergoing HCT for a benign hematologic condition or undergoing outpatient HCT.
  • * Caregivers with a major untreated psychiatric or cognitive condition which the treating oncology clinicians believes interferes with the capacity to provide informed consent.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Massachusetts General Hospital,

Areej El-Jawahri, MD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Jamie Jacobs, PhD, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

2029-02